Skip to main content
SpringerLink
Log in

Influencing prescribing with drug use evaluation

  • Newsletter Article
  • Published:
PharmacoResources

Abstract

D rug use evaluation (DUE) has been employed in the US hospital setting for more than 30 years as a means of influencing the prescribing behaviour of physicians. Recently, federal legislation was introduced requiring DUE for ambulatory patients receiving medication through federally funded programmes. The process of DUE is designed to ensure the rational use of medications in the treatment and prevention of disease, according to Dr Gary Smith from the University of Arizona College of Pharmacy, Tucson, US. †

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Authors
  1. Jo Barnes
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tracey Langsdale
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

† Dr Smith’s comments on the DUE process and its effect on changing prescribing practices were made during a presentation at the 55th World Congress of Pharmacy and Pharmaceutical Sciences held in Stockholm, Sweden, in August this year.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Barnes, J., Langsdale, T. Influencing prescribing with drug use evaluation. Pharmacoecon. Outcomes News 42, 3–4 (1995). https://doi.org/10.1007/BF03309901

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03309901

Keywords

Search

Navigation